STOP-HPV scale-up to increase HPV vaccination in clinics
Official title: The STOP-HPV Scale Up Study
Run by University of California, Los Angeles · NCT06831383 · Data updated 2026-11-12
This trial will test two ways of training clinic teams to see if they increase HPV vaccine starts for 9–12 year olds at well-child visits compared with usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 9 Years to 17 Years |
| Sex | All |
| Enrollment | 100000 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Alexandria, Virginia) |
| Status | Recruiting |
| Started | March 30, 2026 |
| Main results expected | April 19, 2027 |
| Study ends | April 19, 2027 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT06831383 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged about 9 to <13 years who attend a participating practice for a well-child visit and have not yet received any HPV vaccine dose.
✕Probably not a fit
Patients who have already received any HPV vaccine dose or who are outside the eligible age range are unlikely to benefit from the interventions in this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a three-arm, cluster randomized trial that will randomize about 72 primary care practices across up to eight U.S. health systems to one of two implementation strategies or usual care. One arm delivers online provider communication training only (STOP-HPV-Online) and the other adds a Learning Collaborative with performance feedback for practice leads (STOP-HPV-LC); health systems will deploy the interventions with AMGA support as needed. The primary outcome is HPV vaccine initiation among 9 to <13 year olds during a 12-month intervention period, with fidelity monitoring and cost-effectiveness analysis. The design builds on prior work that produced modest improvements when interventions were delivered by the research team and tests whether those gains hold when scaled and run by health systems.
Why it matters
Potential benefit: If successful, the interventions could increase HPV vaccine initiation in age-eligible patients and thereby reduce future HPV-related cancers.
How similar studies have gone: Prior investigator-led studies showed modest increases in initiation (about 6.8% for online training and ~8% when combined with a learning collaborative), but this trial tests whether those effects can be replicated when health systems implement the strategies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient of participating practice * Well child care visit during the 12-month intervention period * No prior dose of HPV vaccine at the time of the well child care visit * Age-eligible Exclusion Criteria: * Prior dose of HPV vaccine
Where it's running
-
Amga
Alexandria, Virginia, United States Recruiting
Study contacts
- Principal investigator: Peter Szilagyi, MD, MPH — University of California, Los Angeles
- Study coordinator: Peter Szilagyi, MD, MPH
- Email: pszilagyi@mednet.ucla.edu
- Phone: 310-206-6328
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CGM-guided carb awareness education for adults with Type 1 diabetes
This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.
-
Protein supplements with or without spices to protect muscle for people on GLP-1 weight loss meds
This pilot test checks whether daily whey protein, with or without mixed spices, helps preserve muscle mass and strength in adults using GLP-1 weight-loss medicines.
-
Diet Quality Matters: A Nutrition Education Program for Los Angeles Food Rx Participants
A community-based program will test whether tailored nutrition education and cooking sessions can help low-income adults in LA improve diet quality and reduce cardiometabolic risk.
-
Diet quality in older adults and how two dietary tools compare
This study tests two diet-quality questionnaires in adults 60 and older who use LA Food Rx produce programs to see which better reflects their eating and BMI.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
-
Care Disengagement Prevention for People Living with HIV in Indonesia
This intervention tests a stigma-reduction approach to help people living with HIV in Indonesia stay connected with HIV care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.